Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Yi Zhao

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry|March 15, 2018
Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitorsMinhang Xin, Weiming Duan, Yifan Feng, et al.
Journal of Medicinal Chemistry|November 19, 2024
Lysine-Targeted Covalent Inhibitors of PI3Kδ Synthesis and Screening by In Situ Interaction UpgradationBo Yuan, Yifan Feng, Mengyan Ma, et al.
Bioorganic & Medicinal Chemistry|March 27, 2018
Synthesis and evaluation of 2,9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitorsYuan-Yuan Hei, Ying Shen, Jin Wang, et al.
European Journal of Medicinal Chemistry|September 5, 2020
Discovery of potent small molecule PROTACs targeting mutant EGFRHong-Yi Zhao, Xue-Yan Yang, Hao Lei, et al.
European Journal of Medicinal Chemistry|January 18, 2020
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)Hao Zhang, Hong-Yi Zhao, Xiao-Xiao Xi, et al.
Toxicology and Applied Pharmacology|February 25, 2025
EGFR tyrosine kinase inhibitor ZZC4 overcomes acquired resistance to gefitinibMawusse K I Attiogbe, Ting-Ting Huang, Hong-Yi Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2026
Albumin-Bound STING Agonist Reprograms HSPCs to Antitumor Neutrophils Enhancing CD8<sup>+</sup> T Cell ImmunityJinsong Tao, Hong-Yi Zhao, Chengyi Li, et al.
European Journal of Medicinal Chemistry|February 22, 2018
Discovery of 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as new EGFR-TKIsHao Zhang, Jin Wang, Ying Shen, et al.
Journal of Medicinal Chemistry|March 7, 2022
Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR LigandsHong-Yi Zhao, Hai-Peng Wang, Yu-Ze Mao, et al.
Journal of Medicinal Chemistry|May 19, 2025
Design of Potent Small-Molecule Stimulator of Interferon Gene Inhibitor and Stimulator of Interferon Gene Mutant-Specific DegraderHong-Yi Zhao, Luchen Zhang, Zhongwei Liu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|March 15, 2018
Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitorsMinhang Xin, Weiming Duan, Yifan Feng, et al.
Journal of Medicinal Chemistry|November 19, 2024
Lysine-Targeted Covalent Inhibitors of PI3Kδ Synthesis and Screening by In Situ Interaction UpgradationBo Yuan, Yifan Feng, Mengyan Ma, et al.
Bioorganic & Medicinal Chemistry|March 27, 2018
Synthesis and evaluation of 2,9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitorsYuan-Yuan Hei, Ying Shen, Jin Wang, et al.
European Journal of Medicinal Chemistry|September 5, 2020
Discovery of potent small molecule PROTACs targeting mutant EGFRHong-Yi Zhao, Xue-Yan Yang, Hao Lei, et al.
European Journal of Medicinal Chemistry|January 18, 2020
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)Hao Zhang, Hong-Yi Zhao, Xiao-Xiao Xi, et al.
Toxicology and Applied Pharmacology|February 25, 2025
EGFR tyrosine kinase inhibitor ZZC4 overcomes acquired resistance to gefitinibMawusse K I Attiogbe, Ting-Ting Huang, Hong-Yi Zhao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 19, 2026
Albumin-Bound STING Agonist Reprograms HSPCs to Antitumor Neutrophils Enhancing CD8<sup>+</sup> T Cell ImmunityJinsong Tao, Hong-Yi Zhao, Chengyi Li, et al.
European Journal of Medicinal Chemistry|February 22, 2018
Discovery of 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as new EGFR-TKIsHao Zhang, Jin Wang, Ying Shen, et al.
Journal of Medicinal Chemistry|March 7, 2022
Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR LigandsHong-Yi Zhao, Hai-Peng Wang, Yu-Ze Mao, et al.
Journal of Medicinal Chemistry|May 19, 2025
Design of Potent Small-Molecule Stimulator of Interferon Gene Inhibitor and Stimulator of Interferon Gene Mutant-Specific DegraderHong-Yi Zhao, Luchen Zhang, Zhongwei Liu, et al.
Pageof 5